| Followers | 0 |
| Posts | 48 |
| Boards Moderated | 0 |
| Alias Born | 06/06/2022 |
Wednesday, November 30, 2022 11:01:38 PM
You can’t be serious. Why dilute if you are finalizing a deal? Makes no sense. Management would be lowering their own profits on the share sale if they would do this. Would you rather sell your shares for $1 or dilute your own company with a deal in hand and sell your shares for $0.75?
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
